Silo Wellness Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Silo Wellness's earnings have been declining at an average annual rate of -4%, while the Pharmaceuticals industry saw earnings growing at 51% annually. Revenues have been growing at an average rate of 69.3% per year.
Wichtige Informationen
-4.0%
Wachstumsrate der Gewinne
57.5%
EPS-Wachstumsrate
| Pharmaceuticals Wachstum der Industrie | 23.1% |
| Wachstumsrate der Einnahmen | 69.3% |
| Eigenkapitalrendite | n/a |
| Netto-Marge | 185.2% |
| Letzte Ertragsaktualisierung | 31 Jul 2023 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Silo Wellness Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Jul 23 | 0 | 1 | 4 | 0 |
| 30 Apr 23 | 0 | -1 | 4 | 0 |
| 31 Jan 23 | 0 | -5 | 5 | 0 |
| 31 Oct 22 | 0 | -6 | 5 | 0 |
| 31 Jul 22 | 0 | -5 | 3 | 0 |
| 30 Apr 22 | 0 | -4 | 4 | 0 |
| 31 Jan 22 | 0 | -7 | 5 | 0 |
| 31 Oct 21 | 0 | -6 | 5 | 0 |
| 31 Jul 21 | 0 | -5 | 4 | 0 |
| 30 Apr 21 | 0 | -5 | 3 | 0 |
| 31 Jan 21 | 0 | -1 | 1 | 0 |
| 31 Oct 20 | 0 | -1 | 1 | 0 |
Qualität der Erträge: SILO has a large one-off gain of $3.0M impacting its last 12 months of financial results to 31st July, 2023.
Wachsende Gewinnspanne: SILO became profitable in the past.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: SILO has become profitable over the past 5 years, growing earnings by -4% per year.
Beschleunigtes Wachstum: SILO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Erträge im Vergleich zur Industrie: SILO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (39.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: SILO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.